You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Microtubule Star (MTS) Antibodies

Full name:
anti-Microtubule Star Antibodies (MTS)
On are 4 Microtubule Star (MTS) Antibodies from 4 different suppliers available. A total of 4 Microtubule Star products are currently listed.
AI115466, D8Ertd766e, PP2Ac, PP2CA, PP2Calpha, RP-C
list all antibodies Gene Name GeneID UniProt
MTS 19053 P62715
MTS 5515 P67775

Show all species

Show all synonyms

Most Popular Reactivities for anti-Microtubule Star (MTS) Antibodies

Select your species and application

anti-Mouse (Murine) Microtubule Star Antibodies:

anti-Human Microtubule Star Antibodies:

anti-Rat (Rattus) Microtubule Star Antibodies:

All available anti-Microtubule Star Antibodies

Go to our pre-filtered search.

Top referenced anti-Microtubule Star Antibodies

  1. Mouse (Murine) Monoclonal Microtubule Star Primary Antibody for IP, WB - ABIN1042659 : Hombauer, Weismann, Mudrak, Stanzel, Fellner, Lackner, Ogris: Generation of active protein phosphatase 2A is coupled to holoenzyme assembly. in PLoS biology 2007 (PubMed)
    Show all 8 references for ABIN1042659

More Antibodies against Microtubule Star Interaction Partners

Mouse (Murine) Microtubule Star (MTS) interaction partners

  1. PP2B-Abeta (show APP Antibodies) limits platelet response to vascular injury by suppressing outside-in alphaII b beta3 integrin (show ITGB3 Antibodies) signaling

  2. TRPV1 (show TRPV1 Antibodies) activation in endothelial cells may elicit a Ca(2 (show CA2 Antibodies)+) -dependent effect on PP2B-PKC (show PKC Antibodies) signalling, which leads to dephosphorylation of eNOS (show NOS3 Antibodies)

  3. PP2A (show PPP2R2B Antibodies) activation via rapid, non-nuclear ER signaling may be a novel target for therapeutic approaches to inhibit vascular smooth muscle proliferation, which plays a central role in atherosclerosis and restenosis.

  4. This study provides evidence that CaBP4 (show CABP4 Antibodies) is dephosphorylated by PP2A (show PPP2R2B Antibodies) in the retina.

  5. generated conditional null alleles of Ppp2ca (show PPP2CA Antibodies) and Ppp2cb (show PPP2CA Antibodies) by flanking with loxP sites exons 3 to 5 of Ppp2ca (show PPP2CA Antibodies) and exon 3 of Ppp2cb (show PPP2CA Antibodies). Ppp2ca (show PPP2CA Antibodies)(fl/fl (show FLT3LG Antibodies)) mice did not display any visible phenotype

  6. calcineurin (show PPP3CA Antibodies) signaling plays a critical role in regulating skeletal muscle fiber type switching but not hypertrophy

  7. Protein phosphatase 2Ac (alpha) can negatively regulate integrin alpha(IIb (show ITGA2B Antibodies))beta(3) signaling by suppressing the ERK1/2 (show MAPK1/3 Antibodies) signaling pathway

  8. PP-2A is less abundant than PP-1 (show PPP1CC Antibodies) in the mouse eye and appear to be highly regulated by various regulatory subunits; the genes encoding PP-1alpha/beta, PP-2Aalpha/beta, PP-2A-Aalpha/beta, and PP-2A-B alpha/beta/gamma are all differentially expressed.

  9. PP2A (show PPP2R2B Antibodies)/C provides a dual inhibitory effect on Bcl2 (show BCL2 Antibodies)'s survival function by both dephosphorylating Bcl2 (show BCL2 Antibodies) and enhancing p53 (show TP53 Antibodies)-Bcl2 (show BCL2 Antibodies) binding.

Human Microtubule Star (MTS) interaction partners

  1. PP2Ac (show PPP2CA Antibodies) upregulation has a poor prognostic impact on the overall survival of hepatocellular carcinoma (HCC (show FAM126A Antibodies)) patients and contributes to the aggressiveness of HCC (show FAM126A Antibodies). PP2Ac (show PPP2CA Antibodies) may represent a potential therapeutic target for HCC (show FAM126A Antibodies).

  2. Data show that downregulating proto-oncogene (show RAB1A Antibodies) protein Akt (p-Akt (show AKT1 Antibodies)) by inhibiting PP2A (show PPP2R4 Antibodies) inhibitor SET-mediated protein phosphatase 2A (PP2A (show PPP2R4 Antibodies)) inactivation determined the pro-apoptotic effects of EMQA and paclitaxel combination treatment.

  3. Data suggest a critical role for the I2PP2A (show SET Antibodies) protein (SET)-protein phosphatase-2A (PP2A (show PPP2R4 Antibodies)) signaling axis in Pten (show PTEN Antibodies) protein (Pten (show PTEN Antibodies)) deficient castration resistant prostate cancer (CRPC) progression.

  4. that loss of glucocerebrosidase (show GBA Antibodies) function may contribute to SNCA (show SNCA Antibodies) accumulation through inhibition of autophagy via PPP2A inactivation

  5. Both PP-1 (show PPA1 Antibodies) and PP-2A are directly involved in regulating eye development, and are aberrantly expressed in cataract and glaucoma patients. (Review)

  6. Data suggest that activation of TAZ (tafazzin (show TAZ Antibodies)) inhibits adipogenesis in mesenchymal stem cells; interaction of TAZ (show TAZ Antibodies) and protein phosphatases (PP1A (show PPP1CA Antibodies), PP2A (show PPP2R4 Antibodies)) up-regulates dephosphorylation and transport of TAZ (show TAZ Antibodies) to cell nucleus.

  7. Data show that loss of epithelial membrane protein 2 (EMP2) is involved in sphingosylphosphorylcholine (SPC (show UCN3 Antibodies))-induced phosphorylation of keratin 8 (show KRT8 Antibodies) (K8) via ubiquitination of protein phosphatase 2 (PP2A (show PPP2R4 Antibodies)) through alpha4 phosphoprotein (show IGBP1 Antibodies) by caveolin-1 (cav-1 (show CAV1 Antibodies)).

  8. Data show that the protein phosphatase 2A (PP2A (show PPP2R4 Antibodies))/c-jun N-Terminal Kinase (JNK)/Sp1 transcription factor (show SP1 Antibodies)/CDK1 (show CDK1 Antibodies) kinase pathway and the autophagy/cyclin (show PCNA Antibodies) kinase inhibitor p21 (show CDKN1A Antibodies) pathway participated in G2/M cell cycle arrest triggered by PP2A (show PPP2R4 Antibodies) inhibitors.

  9. Data indicate that LB100 attenuates protein phosphatase 2A (PP2A (show PPP2R4 Antibodies)) activity alone and following radiation.

  10. Concurrent mTORC1 inactivation and PP2A (show PPP2R4 Antibodies)-B55alpha (show PPP2R2A Antibodies) stimulation fuel ULK1 (show ULK1 Antibodies)-dependent autophagy.

Microtubule Star (MTS) Antigen Profile

Antigen Summary

This gene encodes the phosphatase 2A catalytic subunit. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. This gene encodes an alpha isoform of the catalytic subunit.

Alternative names and synonyms associated with Microtubule Star (MTS)

  • protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform (Ppp2cb) antibody
  • protein phosphatase 2, catalytic subunit, alpha isozyme (PPP2CA) antibody
  • AI115466 antibody
  • D8Ertd766e antibody
  • PP2Ac antibody
  • PP2CA antibody
  • PP2Calpha antibody
  • RP-C antibody

Protein level used designations for anti-Microtubule Star (MTS) Antibodies

PP2A-beta , protein phosphatase 2a, catalytic subunit, beta isoform , serine/threonine-protein phosphatase 2A catalytic subunit beta isoform , PP2A-alpha , protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform , protein phosphatase 2A catalytic subunit, alpha isoform , replication protein C , serine/threonine protein phosphatase 2A, catalytic subunit, alpha isoform , serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform

19053 Mus musculus
5515 Homo sapiens
Selected quality suppliers for anti-Microtubule Star (MTS) Antibodies
Did you look for something else?